Quantifying spatial CXCL9 distribution with image analysis predicts improved prognosis of triple-negative breast cancer
Open Access
- 18 June 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 15, 1421573
Abstract
Background: The C-X-C motif chemokine ligand 9 (CXCL9) plays a pivotal role in tumor immunity by recruiting and activating immune cells. However, the relationship between CXCL9 expression and prognosis in triple-negative breast cancer (TNBC) is unclear.Methods: We investigated CXCL9 mRNA expression, clinicopathological features, and prognosis in TNBC patients. We also used computational image analysis to quantify and assess the distribution of CXCL9 protein in the tumor core (TC) and invasive margin (IM).Results: CXCL9 mRNA expression was significantly higher in TNBC tumors compared to normal tissue (p < 0.001) and was associated with smaller tumors (p = 0.022) and earlier stages (p = 0.033). High CXCL9 mRNA expression was correlated with improved overall survival (OS) in three independent cohorts (all p < 0.05). In a separate analysis, low CXCL9 protein expression was associated with increased lymph node metastasis (p = 0.018 and p = 0.036). High CXCL9 protein expression in the TC, IM, or both was associated with prolonged OS (all p < 0.001).Conclusion: High CXCL9 expression, at both the mRNA and protein levels, is associated with improved prognosis in TNBC patients. CXCL9 expression in the TC and/or IM may be an independent prognostic factor.Keywords
This publication has 40 references indexed in Scilit:
- CXCL9 influences the tumor immune microenvironment by stimulating JAK/STAT pathway in triple-negative breast cancerCancer Immunology, Immunotherapy, 2022
- Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome GraphsCell, 2020
- CXC Chemokine Receptors in the Tumor Microenvironment and an Update of Antagonist Development2020
- The Role of CXCL13 and CXCL9 in Early Breast CancerClinical Breast Cancer, 2020
- Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 TherapyImmunity, 2019
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsCancer Cell, 2019
- CD36 deficiency attenuates immune‐mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10Hepatology, 2018
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapyThe Lancet Oncology, 2018
- Chemokines in the cancer microenvironment and their relevance in cancer immunotherapyNature Reviews Immunology, 2017
- Immunohistochemical expression and localization of cytokines/chemokines/growth factors in gastric cancerCytokine, 2017